BridgeMD
New treatment option for Chronic Musculoskeletal Pain
Official title Pain Disengagement Training (Open Pilot)
ClinicalTrials.gov ID: NCT06870162
What this study is testing
- What it's testing
- The investigators aim to conduct an open pilot trial to determine the initial feasibility of a self-directed writing-based intervention in individuals with chronic musculoskeletal pain and elevated pain catastrophizing. The investigators will assess the feasibility of recruitment, acceptability of the treatment, credibility and participant satisfaction, treatment adherence, and feasibility of assessments following pre-specified benchmarks.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Outpatient adults (i.e., greater than or equal to 18)
- Has self reported chronic musculoskeletal pain (i.e., pain persisting for at least 3 months)
- Pain score greater than or equal to 4 (moderate) on the Numerical Rating Scale
- Pain catastrophizing score greater than or equal to 20 on Pain Catastrophizing Scale
- Willingness to engage in a writing-based intervention and self-reported ability to write or type for at least 30 minutes in a sitting
You likely can't join if
- Clinically significant change in therapy or medication in the past 3 months
- Severe untreated mental health condition (e.g., psychosis)
- Active suicidality with history of plan or current intent
- Serious illness expected to worsen in the next 6 months (e.g., cancer)
- Untreated substance use problem that, per patient's self-report, would interfere with the ability to complete the intervention.
See the full eligibility criteria
- Outpatient adults (i.e., greater than or equal to 18)
- Has self reported chronic musculoskeletal pain (i.e., pain persisting for at least 3 months)
- Pain score greater than or equal to 4 (moderate) on the Numerical Rating Scale
- Pain catastrophizing score greater than or equal to 20 on Pain Catastrophizing Scale
- Willingness to engage in a writing-based intervention and self-reported ability to write or type for at least 30 minutes in a sitting
- Received care at Massachusetts General Hospital
- English verbal and writing fluency
- Clinically significant change in therapy or medication in the past 3 months
- Severe untreated mental health condition (e.g., psychosis)
- Active suicidality with history of plan or current intent
- Serious illness expected to worsen in the next 6 months (e.g., cancer)
- Untreated substance use problem that, per patient's self-report, would interfere with the ability to complete the intervention.
The study team makes the final eligibility decision.
Where it's taking place
- Boston, Massachusetts, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Boston, Massachusetts, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.